Drugs in MeSH Category Leprostatic Agents
✉ Email this page to a colleague
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epic Pharma Llc | RIFAMPIN | rifampin | INJECTABLE;INJECTION | 065502-001 | Sep 21, 2010 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Taro | DAPSONE | dapsone | TABLET;ORAL | 209430-002 | Mar 1, 2019 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sun Pharma Canada | DAPSONE | dapsone | GEL;TOPICAL | 210191-001 | Jun 26, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Rising | DAPSONE | dapsone | TABLET;ORAL | 207165-002 | Jul 20, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Macleods Pharms Ltd | DAPSONE | dapsone | TABLET;ORAL | 218335-002 | Jul 8, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Lupin Pharms | RIFAMPIN | rifampin | CAPSULE;ORAL | 090034-002 | Aug 21, 2013 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Zydus Lifesciences | DAPSONE | dapsone | GEL;TOPICAL | 214019-001 | May 8, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
